About: acn

香港，2025年9月17日 - (亞太商訊 via SeaPRwire.com) - 9月11日，在2025中國國際服務貿易交易會（簡稱“服貿會”）中醫藥主題日暨第十届海外華僑華人中醫藥大會期間，北京同仁堂國藥有限公司（03613.HK）與烏拉圭國家肉類協會正式簽署《傳統醫藥合作備忘錄》（MOU），標志著兩國在傳統醫藥領域的合作邁入實質性推進階段，爲中醫藥國際化進程注入新動能。 在雙方的見證下，同仁堂國藥公司（03613.HK）主要負責人嚴晗，與烏拉圭國家肉類協會主席加斯頓·斯卡約拉（GASTóNSCAYOLAPIEDRACUEVA）現場簽署了合作備忘錄。此次簽約是雙方歷經多輪溝通、逐步深化共識的必然結果。烏拉圭國家肉類協會主席加斯頓·斯卡約拉在接受媒體采訪時高興地表示，與擁有356年歷史的同仁堂簽署合作備忘錄是此次服貿會之行的最大收穫。對擁有400餘年畜牧業史的烏拉圭而言，此次合作備忘錄的簽署不僅推動了中醫藥惠及當地、促進中西醫融合，更激發了未來無限的合作可能。他希望雙方携手前行，共同爲全球自由貿易與多邊主義努力奮鬥。 烏拉圭駐華大使館代辦馬丁·奧蘭多表示，此次烏拉圭肉類協會主席率隊到場幷與同仁堂簽署戰略合作備忘錄，將爲深化中國-烏拉圭雙邊關係增添新動力。簽約儀式後，烏拉圭國家肉類協會及駐華使館代表團一行來到同仁堂展位，仔細參觀了展陳的經典中成藥與特色養生品，幷不時駐足詢問産品功效與研發理念。他們仔細欣賞同仁堂在東南亞、歐洲等地的國際化成果圖展，瞭解同仁堂境外門店的日常運營模式及本地化産品的研發邏輯，對同仁堂在境外市場的深耕實踐成果紛紛表示贊許，對中醫藥煥發出的蓬勃生機與走向國際的豐碩成果表示高度認可。相信隨著合作備忘錄的逐步落實，未來，雙方必將秉持共贏理念，不斷完善傳統醫藥原材料輸華的全流程管控，探索中醫藥服務與烏拉圭本地健康需求的深度融合，開發更多具有中烏特色的健康産品，助力中醫藥在世界舞臺綻放更耀眼的光彩。 Copyright 2025 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

Vancouver, British Columbia--(ACN Newswire via SeaPRwire.com - September 17, 2025) - Casa Minerals Inc. (TSXV: CASA) (OTCQB: CASXF) (FSE: 0CM) (the "Company" or "Casa") is pleased to announce that it has received partial results from the 3D ground-based Induced Polarization ("IP") survey recently completed at its highly prospective copper-silver-lead-zinc Arsenault property located in northern British Columbia, close to the Yukon-B.C. border.The geophysical contractor employed state-of-the-art instruments with dipoles at 100m station spacing to dimensions of 15m in subsurface high density data acquisition. The survey consists of 60 km of parallel lines with 200m line spacing that covered approximately 12 square kms at the heart of the 96.5 square kilometer (37.3 sq. mile) Arsenault property. The property is located in "Big Salmon" geological terrain comprising volcano-sedimentary formations that elsewhere are host to important VMS and precious metals deposits.Data acquired in the field is now being processed to present two dimensional drawings (pseudo-sections) that depict ground mass resistivity and chargeability and are being received daily. Survey lines are spaced at 200 metres and controlled by GPS. Figures 1 to 6 illustrate the resulting Induced Polarization and Resistivity that are interpreted to reflect characteristics of the underlying bedrock.In addition to the recent survey and other work by its own crews, Casa has a large database of similar geophysical work, geochemical surveys, geological mapping, and trenching.An airborne VTEM survey in 2017 revealed five compelling exploration targets of low resistivity coincident with strong geochemistry in volcanic members of Big Salmon rocks. As shown in the accompanying drawings, the 2025 advanced 3D ground IP survey is highlighted by strong geophysical signatures that confirm most of the pre-existing data including that from a previously flown Airborne Electromagnetic ("EM") survey (2017). The colour-coded pseudo-sections show a pattern of high to very high chargeability responses as well as an array of resistivity responses from very low to high but due in part to widely varying electrical characteristics inherent in different rock and mineral types, do not allow confident assignment of anomalies to rock (or mineral) types. Ultimately confirmation will be with further, more-detailed surveys, trenching and drilling.Casa's management team has extensive experience in applying technical data in the search for valuable base and precious metal deposits. Plans to advance the Arsenault property are being finalized with an objective of entering the drilling phase.Areas of particularly strong technical signatures will be the focus of the initial drilling campaign. The Company has conducted consultations with the Teslin-Taku First Nation and has a drill permit from the provincial of British Columbia. A drill program will be with personnel accommodated in a temporary camp. All environmental and social protocols will be strictly observed.Figure 1: Line 27E Alpha IP SurveyTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/1750/266791_figure%201%20-%20line%2027e.jpgFigure 2: Line 26E Alpha IP SurveyTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/1750/266791_figure%202%20-%20line%2026e.jpgFigure 3: Line 25E Alpha IP SurveyTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/1750/266791_figure%203%20-%20line%2025e.jpgFigure 4: Line 24E Alpha IP SurveyTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/1750/266791_figure%204%20-%20line%2024e.jpgFigure 5: Line 23E Alpha IP SurveyTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/1750/266791_figure%205%20-%20line%2023e.jpgFigure 6: Line 22E Alpha IP SurveyTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/1750/266791_figure%206%20-%20line%2022e.jpgThe VTEM Airborne geophysical survey depicts the acquired IP line locations and in relation to the VTEM identified targets.To view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/1750/266791_casafig7.jpgThe Following the 3D Presentation of Induced Polarization and Resistivity sections completed to date. To view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/1750/266791_ba4ecde4b41aa932_008full.jpg"The 3D IP ground survey with its high resolution will help us define our future exploration at the Arsenault Project," commented Farshad Shirvani, President and CEO of Casa Minerals. "I recently had the pleasure of visiting the Project and seeing firsthand what has enticed previous explorers over decades. Our field crews have examined numerous rock samples that exhibit strong sulphide mineralization including some that conceptually may be related to the mysterious deep-sea "black smokers" the signature of volcanogenic massive sulphide deposits. We are looking forward to seeing additional results of this sophisticated technical survey that undoubtedly will help us understand the subsurface geology without incurring significant environmental impact."About the Arsenault Project Casa Minerals Inc. is aiming to exercise the option to acquire 75% ownership. It has fulfilled requirements of share issuance and is committed to fulfill its exploration expenditure and payment obligations which were accrued and postponed due to market conditions. For further details, please see the Company's MD&A filed on SEDAR+.About Casa Minerals Inc.Casa Minerals Inc. is a company engaged in gold exploration in two prominent regions: Arizona and British Columbia, Canada. The company is involved in gold exploration on the Congress Gold Mine, a past-producing mine located in Arizona. The company is also active in copper-gold exploration in British Columbia, Canada. Casa Minerals' management team has a track record of numerous discoveries in the exploration sector. The Company is committed to creating shareholder value through the discovery and development of economic mineral deposits.For more information, please visit the company's website at https://www.casaminerals.com/.On Behalf of the Board of DirectorsFarshad Shirvani, M.Sc. Geology President, CEO and DirectorFor more information, please contact:Casa Minerals Inc.Farshad Shirvani, President & CEOPhone: (604) 678-9587Email: farshad@casaminerals.comhttps://www.casaminerals.comNEITHER TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/266791 Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

SEOUL, SOUTH KOREA, Sept 17, 2025 - (ACN Newswire via SeaPRwire.com) - Seoul's bio startup hub 'Seoul Bio Hub' and global pharmaceutical leader 'Celltrion' have joined forces to launch the '2025 Seoul Bio Hub-Celltrion Global Open Innovation (GOI)' program. This program goes beyond a simple competition, serving as a platform designed to help U.S. startups successfully establish themselves in the Asian market.This GOI targets U.S.-based bio and medical startups, with companies established within the past 7 years eligible to apply. The recruitment areas encompass all technologies suitable for collaboration with Celltrion, including antibodies, peptides, small molecules, formulations, and cell and gene therapies.The application deadline is September 30, 2025. The selection process will proceed in the following order:Primary document evaluationTechnology reviewSecondary presentation evaluation.The two finally selected companies will receive customized follow-up support and gain opportunities to expand into global markets through collaboration with Celltrion, leveraging South Korea's innovative ecosystem and global capabilities.A Seoul Bio Hub representative stated, "This program will serve as a bridgehead that goes beyond simple space support, enabling U.S. startups to rapidly grow in the Asian market by leveraging Seoul's excellent clinical infrastructure and research environment."A Celltrion representative announced, "Based on Celltrion's capabilities and know-how accumulated across the entire pharmaceutical industry process including R&D, production, and sales, we will support promising U.S. startups to successfully enter the Asian market and create synergy with our company."South Korea has established itself as a bio hub leading the global market with clear numerical evidence. According to global consulting firm Intralink, South Korea's biopharmaceutical market is valued at approximately $22 billion, ranking 13th globally.Additionally, market research firm Grand View Research forecasts that South Korea's biotechnology market will grow to $81.6 billion (approximately 110 trillion KRW) by 2030, representing an annual average growth rate of 18.3%.Private investment is also active. From 2020 to 2022, R&D and facility investments recorded an annual average growth rate of 21.6%. This demonstrates that South Korea is not merely a potential market, but a rapidly growing innovation ecosystem.According to ClinicalTrials.gov, the global clinical trial database, Seoul has consistently maintained a top position among major global cities in the number of new clinical trials over the past decade.South Korea's Ministry of Health and Welfare has set 'Achieving Global 3rd Place in Clinical Trials' as a policy objective through the '3rd Five-Year Plan for the Pharmaceutical and Bio Industry (2023-2027)'. Furthermore, in 2025, it raised a total of over 386.6 billion KRW through the 'Bio Health Mega Fund' and is actively supporting innovative companies' clinical trials and commercialization through the national integrated bio big data construction project and AI, bio health regulatory regulatory sandboxes.Seoul Bio Hub is a bio startup support organization established by Seoul City in 2017. It provides 251 pieces of shared laboratory equipment and affordable tenant space at 10% of the cost compared to major areas in Seoul. As of May 2025, it has supported 322 startups and attracted a total of 576 billion KRW in follow-up investment, proving its potential for success.Celltrion is South Korea's global comprehensive biotechnology company that developed the world's first antibody biosimilar 'Remsima'. The company performs the entire process from research and development to approval, production, and sales, supplying high-quality biopharmaceuticals to over 100 countries worldwide. Based on world-class research and production infrastructure, it contributes to expanding global access to pharmaceuticals and continues to support and collaborate with promising startups through active open innovation strategies.For detailed information regarding program applications and inquiries, please access LinkedIn, search for 'Seoul Bio Hub', and check the '2025 Seoul Bio Hub-Celltrion Global Open Innovation' recruitment announcement posted on the official company page.About Seoul Bio Hubhttps://www.seoulbiohub.kr/front/user/engmain.doEstablishment Date: October 30, 2017Operating Entity: Established by Seoul City / Joint operation by KIST and Korea UniversityLocation: 117-3 Hoegi-ro, Dongdaemun-gu, Seoul, Republic of KoreaPurpose: Growth and commercialization support for early-stage bio and healthcare startups under 10 yearsTenant Companies (As of June 2025): Total 126 companies (Digital Health 42 companies (33.3%), Pharmaceuticals 61 companies (48.5%), Medical Devices 23 companies (18.2%))Infrastructure: Laboratories, office spaces, meeting rooms, conference rooms, research equipment (249 devices, 109 types, approximately $8 million scale)Research and Human Resource Network (Regional): Approximately 7,000 PhD-level personnel, approximately 120,000 university students, $1.13 billion in research funding, connections with 12 universities and research institutions and 7 hospitalsMajor Support Programs:IR matching and investment linkageExpert consulting and CEO educationHospital-linked clinical and data programsOpen innovation with domestic and international pharmaceutical companiesAbout Celltrionhttps://www.celltrion.com/en-usEstablishment Date: February 26, 2002Location (Headquarters): 23 Academy-ro, Yeonsu-gu, Incheon Metropolitan City, Republic of KoreaBusiness Areas and Major Products (Services)Possessing Differentiated Integrated Solutions Across the Entire Biopharmaceutical Business ProcessRemsima: World's first monoclonal antibody biosimilar (TNF-α inhibitor)Herzuma: Trastuzumab biosimilar for breast and gastric cancer treatmentTruxima (CT-P10): Rituximab biosimilar (lymphoma, rheumatoid arthritis, etc.)Multiple products including Zymfentra, Yuflyma, Vegzelma, Steqeyma, Avtozma are under global approval and commercializationNo of Employees: Approx. 3,003 (As of June 30, 2025)Media ContactBrand: SEOUL BIO HUBContact: Lee Yoon JinPhone: +82 02-2200-3345Website: (KOR) https://www.seoulbiohub.kr/front/user/main.do;(ENG) https://www.seoulbiohub.kr/front/user/engmain.do Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HONG KONG, Sep 17, 2025 - (ACN Newswire via SeaPRwire.com) – The Hong Kong Trade Development Council (HKTDC) welcomes the Policy Address delivered today by Hong Kong SAR Chief Executive John Lee.It outlines a wide-ranging set of initiatives, including deepening international exchange and cooperation and supporting mainland enterprises in overseas expansion. These measures inject strong momentum into Hong Kong’s continued growth.Prof Frederick Ma, Chairman of the HKTDC, said: “The Policy Address reflects the Hong Kong SAR Government’s commitment to innovation and excellence. A diverse set of policy measures – from establishing the Task Force on Supporting Mainland Enterprises in Going Global to setting up the Economic and Trade Express, from injecting $1.43 billion into the BUD Fund to supporting the HKTDC’s E-Commerce Express and Hong Kong Shopping Festival – shows the Hong Kong SAR Government’s commitment to showcasing Hong Kong’s role as a superconnector, super value-adder and a high value-added supply chain service centre.”The Chief Executive unveiled the creation of the GoGlobal Task Force to be steered by the Secretary for Commerce and Economic Development, the Economic and Trade Express jointly formed by Economic and Trade Offices as well as overseas offices of InvestHK and the HKTDC.These efforts will enable not only Hong Kong enterprises to expand overseas, but also mainland companies to go global via the Hong Kong platform, helping them tap into new markets and business opportunities.Also, the Hong Kong SAR Government and HKTDC will bolster IP financing at the Business of IP Asia Forum to promote Hong Kong as a regional IP trading centre.Prof Ma commented: “Amid significant changes in international trade and supply chains, the HKTDC will leverage its network of 51 offices in mainland and overseas as well as years of experience in business matching through conferences and exhibitions. We will actively support the initiatives proposed in the Policy Address and work closely with relevant departments to capitalise on Hong Kong’s unique advantages as a connector linking Mainland China and the world.”The HKTDC has been committed in helping SMEs embrace innovation and technology and enhance their competitiveness in key areas, such as digital transformation and supply chain solutions.The Chief Executive has proposed various measures to support the continued organisation of the Hong Kong Shopping Festival under the HKTDC’s E-Commerce Express, covering the mainland and ASEAN e-commerce markets.The proposed implementation of the Creativity • E-commerce - Beyond Limits programme by organisations, including the Hong Kong SAR Trade and Industry Department and the HKTDC and promotion of the digitalisation of trade to lower costs and improve efficiency are among other initiatives highlighted.Prof Ma welcomes these measures, noting they will strengthen competitiveness of Hong Kong enterprises and products in the international market.The HKTDC will continue to align with overall national development and the policy direction of the Hong Kong SAR Government to continue to support SMEs, bring together the business community and proactively attract mainland enterprises to use Hong Kong as a platform to go global – all to drive reform and innovation as well as sustainable economic growth.Media enquiriesPlease contact the HKTDC’s Communication & Public Affairs Department:Agnes WatSam HoTel: (852)2584 4554Tel: (852)2584 4569Email: agnes.ky.wat@hktdc.orgEmail: sam.sy.ho@hktdc.orgAbout HKTDCThe Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in Mainland China, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

香港，2025年9月17日 - (亞太商訊 via SeaPRwire.com) - 近日，港股上市公司東吳水泥（00695.HK）的股權變更，投下一石激起千層浪，預示著一場前所未有的戰略轉型正冉冉升起。蘇州國資體系通過港航集團（香港）投資有限公司（港航香港）與蘇州汾源資本管理有限公司（汾源資本）戰略入股，首次實現對港股上市公司的控股，更被視為長三角國資體系與境外資本市場深度融合的標誌性事件。這一交易標誌著公司控股權結構的重大變化，更傳遞出公司徹底告別傳統水泥業務，開啟戰略轉型的新信號。依託蘇州國資強大的資源支持和政策賦能，市場的目光紛紛聚焦這股位處長三角中心的雄厚國資力量的入場，東吳水泥未來業務將迎來前所未有的發展機遇。構建蘇港協同新機制，賦能企業戰略轉型蘇州國資的入主，東吳水泥從原來的民營控股轉變為國有資本主導、多元股東共同治理的混合所有制企業，這種優化將顯著提升公司治理水準和資源整合能力，有助公司獲得更多政策支持和資金投入，注入新的發展動力。而兩家蘇州國資股東背後的產業資源與資本運作能力，和在國家的「雙碳」政策指引下，預示了公司徹底告別傳統水泥生產業，朝著綠色產業及新興經濟領域延伸。其中，港航集團近年積極佈局人工智慧、低空經濟等前沿技術領域，探索無人機物流網路、智慧通航管控平臺、長三角港口群智慧物流體系、港口物流升級等，重點支持低空經濟和長三角一體化領域發展，致力於打造智慧港口、智慧物流、智慧航運等數位化應用場景、“低空+”特色應用場景等。在港航集團深耕這些市場聚焦的熱門領域下，東吳水泥有望迎來新綠洲。展現變革的決心與潛力，釋放積極市場信號因此，在新股東入主後，市場普遍期待東吳水泥能夠堅定實施全面轉型戰略，逐步探索並重點佈局智慧倉儲、現代物流、低空經濟等新興板塊。各方預期，東吳水泥將充分發揮資源與區位優勢，積極打造多元化、前瞻性的產業發展格局，注入新的活力，帶來更具韌性與可持續的成長動能。此外，結合蘇州市推動產業升級的戰略，東吳水泥擬探索“香港資本平臺+蘇州產業落地”的嶄新合作模式，在資本與產業間架起高效橋樑。東吳水泥憑藉香港上市的國際化平臺優勢，將成為蘇州國資首次通過港股市場拓展海外資本和國際資源整合的重要視窗，未來可望協助更多蘇州企業“走出去”並引進高端產業資源。尤其是在國家重點扶持的低空經濟產業，無論是政策紅利還是市場空間均具備巨大的發展潛力與想像空間。投資者將眼見一個堅實且變革中的巨人，在蘇州國資背景下，東吳水泥此次變革及戰略轉型，充分體現了國資對於企業轉型升級的支持力度和投資信心。公司未來針對新興領域的轉型，依託香港國際資本優勢與蘇州實體產業協同，為投資者構建具有前瞻性的全新價值藍圖。這無疑為市場帶來積極信號，也彰顯東吳水泥在新經濟時代中變革的決心與潛力。 Copyright 2025 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

費城，賓夕法尼亞州, 2025年9月17日 - (亞太商訊 via SeaPRwire.com) - TruMerit，作為全球醫療人力發展的領導者，今日推出兩項全新的全球認證，專為從事復健、適應性訓練及康復照護的醫療人員而設。這兩項認證分別為 「全球認證醫療人員－復健專業（CGHW-R）」 與 「全球認證醫療人員－復健高階專業（CGHW-RA）」 。它們專為符合資格的全球醫療人員設計，讓其在通過認證考試後，能夠獲得其復健照護實務經驗與專業能力的國際認可與驗證。這些認證，加上 TruMerit 去年設立的「全球認證護理人員－復健專業（CGN-R）」，旨在推動與提升全球超過二十億需要復健照護人群的相關服務。其中，「CGHW-RA」認證專為具有復健相關學位或文憑的人士設計，包括物理治療、職能治療、語言治療或其他復健相關專業的臨床人員、教育人員與指導老師。「全球認證醫療人員－復健專業（CGHW-R）」認證專為具有復健照護經驗，但未完成復健專業相關高等教育的人士而設計。此類人員包括技術員、輔助人員、護理助理，以及在復健、適應性訓練或康復照護環境中工作的居家或社區健康助理。除了學歷與學位要求外，申請這些認證的候選人，還必須在過去五年內，至少有兩年於復健、適應性訓練或康復照護環境中的工作經驗。在 TruMerit 驗證其資格後，他們必須通過於全球 1,000 多個考場提供的監考考試。2019 年，CARF International（國際康復認證委員會，一家為全球復健照護機構提供認證的非營利組織）曾提醒 TruMerit（當時名為 CGFNS International），指出復健醫療人力在實務能力驗證上的需求日益增加，並且需要在整體照護體系中提升標準。TruMerit 隨後與全球各地的復健專家合作，展開建立基於考試的國際認證之工作，以服務於復健、適應性訓練與康復照護領域的醫療專業人員。該過程涵蓋來自全球各區域與不同收入水準的 45 個國家、超過 200 位領域專家參與。「照護龐大且持續成長的殘障人口，是當今醫療界面臨的最緊迫議題之一。透過認證這些致力於復健照護工作的專業人員之知識與技能，國際認證將推動拓展並強化這支關鍵人力隊伍的努力，幫助其應對未來的挑戰。我們十分感謝這支全球復健照護專家團隊的支持，才讓這些認證得以實現。」TruMerit 全球醫療人力發展研究院院長（並領導此項倡議）Julia To Dutka 如是說。瀏覽更多有關 TruMerit 全球復健認證計畫的資訊。此外，上個月 TruMerit 發布了「全球認證護理人員（CGN）」資格 ，專為基層一般護理人員（註冊護理師，RNs）設計，並同時推出了全新改版的 「護理資格考試」 。關於 TruMerit TruMerit 是全球領先的醫療人力發展機構。前身為 CGFNS International，該組織擁有近 50 年歷史，致力於協助護理人員與其他醫療工作者——以及負責發照與聘用的機構——在尋求在美國及其他國家執業許可時，驗證其教育背景、專業技能與實務經驗，促進其職涯流動性。作為 TruMerit，該機構的使命已擴展為建立符合全球快速變遷健康需求的人力資源能力。透過旗下的全球健康人力發展研究院（Global Health Workforce Development Institute），TruMerit 正在推動以實證為基礎的研究、思想領導與倡議，支持各項醫療人力發展方案，包括全球認可的執業標準與認證，藉此強化醫療工作者的職涯發展途徑。聯絡資訊David St. Johndstjohn@trumerit.org來源: TruMerit Copyright 2025 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

KUALA LUMPUR, Sept 17, 2025 - (ACN Newswire via SeaPRwire.com) - Tsuburaya Productions Co., Ltd. unveils an original illustration for the Ultraman Card Game by Yukinobu Tatsu, the manga artist behind the popular series “DAN DA DAN” that is currently being serialized in Shonen Jump+. Featuring the iconic character “Alien Metron The Hallucination Alien,” this artwork will appear on a promotional card for an upcoming product. This information was released at TSUBURAYA CONVENTION 2025, held on 13 & 14 September at Tokyo Dome City.■「Alien Metron The Hallucination Alien」The illustration depicts Alien Metron dashing through a city at dusk—eerie, yet full of humorous charm. This card will be distributed as a purchase bonus for Booster Pack Vol. 5 “Heroes of the Radiant Dawn” on 31 October 2025.Additionally, a new product type will be released on Friday, December 19, 2025. Titled “Ultra Deck 01 Ultraman Tiga & Ultraman Blazar,” this product will contain a preconstructed deck as well as official gameplay accessories, which will allow players to start playing the game immediately.■「Ultra Deck 01 Ultraman Tiga & Ultraman Blazar」This deck will feature the titular duo Ultraman Tiga and Ultraman Blazar. Alongside reprints of essential cards, this deck will also include cards with brand-new illustrations that will only be available in this product, making it a must-have for players and collectors alike. This epic team-up offers a new perspective on the Ultraman Universe, as these heroes have never appeared in previous Ultraman works together.Official gameplay markers and exclusive sleeves will also be included in this product. The official gameplay markers are cards that cannot be included in a deck, but will help to support game progression by marking changes clearly for both players. The limited-design sleeves will feature both Ultra Heroes together in a single illustration.●Booster Pack 05 Heroes of the Radiant DawnRelease Date：31 October 2025 (Fri)MSRP： MYR 18/pack (excluding tax)Contents- 12 cards per pack- 24 packs per display box- Exclusive PR card with Box purchase: Alien Metron The Hallucination Alien●Yukinobu Tatsu’s Profile 龍幸伸氏 プロフィールYukinobu TatsuIn 2010, he made his debut with “Seiji no Rokugo” in “Monthly Shonen Magazine”.In 2015, he released the one-shot “Renai Saibaihou” in Jump SQ.CROWN. After publishing two more one-shots, he began serializing “DAN DA DAN” for Shonen Jump+ in 2021. ■”DAN DA DAN”An occult battle and coming-of-age story that has sold more than 10 million copies since its release. The story follows Momo Ayase, a high school girl born into a family of spirit mediums, and her classmate Ken “Okarun” Takakura, an occult enthusiast, as they confront various supernatural phenomena. This series is currently being serialized on Shueisha's manga app "Shonen Jump+" (updated every Tuesday).●Ultra Deck 01　Ultraman Tiga ＆ Ultraman BlazarRelease Date：19 December 2025 (Friday)MSRP： MYR 105/pack (excluding tax)Contents-60 card pre-constructed deck (21 card types) ※Including reprints-13 Markers (5 Types)-1 Bonus pack（1 random special design marker (Total 6 types) -70 Sleeves of 1 Design※Product specifications are subject to change.    Ultraman Card Game Product InformationThe Ultraman Card Game is a trading card game designed based on the Ultraman Universe and combines collectability with playability that appeals to both adults and children.Official Name: Ultraman Card GameDistributing countries and regions: Japan, Mainland China, South Korea, Taiwan, Hong Kong, Singapore, Malaysia, Indonesia, Vietnam, Philippines, Thailand, Australia, USA, Canada, Mexico.Distribution areas: Retail, toy stores, and trading card shops in distribution countriesOfficial Sitehttps://ultraman-cardgame.com/Official Social Mediahttps://x.com/ucg_enhttps://linktr.ee/ultramancardgame  (List) Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

香港，2025年9月17日 - (亞太商訊 via SeaPRwire.com) - 在當下健康消費理念日益深入人心的時代，天然椰子水因其天然、健康、清爽的特性，受到消費者的廣泛青睞。IFBH Limited（「IFBH」，6603.HK）作為該領域的領軍企業，始終秉持創新與進取的精神，積極拓展業務版圖，在激烈的市場競爭中脫穎而出，不斷助力行業穩步發展。里程碑式合作 為品牌發展注入強心針9月15日，一場具有里程碑意義的合作在商業領域拉開帷幕。IFBH與央企中糧集團旗下的中糧名莊薈正式簽署戰略合作協議，根據協議內容，雙方將採用線上線下雙軌並行的渠道拓展策略，全方位強化Innococo 100%椰子水的分銷體系。這一合作，不僅為旗下品牌Innococo 100%椰子水引入了一位重磅的全新分銷夥伴，同時亦為公司的品牌發展注入了一劑強心針。據悉，中糧名莊薈是中國大型央企中糧集團在酒類及高端飲品渠道的旗艦平台。中糧名莊薈憑藉遍佈全國的經銷網絡、全品類渠道資源和深厚的供應鏈管理能力，長期服務於多家國際高端品牌，在國內酒水與高端飲品領域樹立了卓越的聲譽，成為最具影響力的分銷平台之一。此次與IFBH的合作，無疑是強強聯合，將為Innococo品牌在中國市場的發展帶來無限可能。此次戰略合作，意義深遠。一方面，充分體現了IFBH首席執行官Pongsakorn Pongsak先生高瞻遠矚的戰略眼光和精准佈局，為公司的長遠發展構築穩固根基。另一方面，通過中糧名莊薈強大的分銷網絡，Innococo 100%椰子水能夠更迅速、更廣泛地進入消費者的視野，滿足市場需求，實現市場份額的大幅躍升，進而鞏固IFBH在中國椰子水市場的領先地位，為公司的長期發展注入源源不斷的動力。業績穩步增長 成功納入港股通彰顯實力得益於積極的業務拓展和精准的市場策略，IFBH業績呈現出顯著增長態勢。中期財報顯示，2025年上半年，公司實現總收益94.5百萬美元，同比增長31.5%，增速跑贏行業平均水平；毛利規模達31.8百萬美元，同比提升15.3%，毛利率維持在健康區間；經調整溢利淨額18.9百萬美元，同比增長13.9%，盈利質量穩步提升。除了亮眼的業績，IFBH進一步迎來了資本市場層面的利好消息。近日，滬深交易所發佈公告，宣佈調整港股通標的證券名單，其中，IFBH憑藉出色的基本面與市場聲譽，成功納入港股通標的證券名單，並於9月8日起正式生效。這一重大利好消息，標誌著符合資格的內地投資者可通過滬港通和深港通機制便捷地投資IFBH的股票，不僅有利于改善公司股票的流動性，吸引更多投資者關注，還將有助於提升公司的市場估值，進一步增強公司在資本市場的影響力。從行業角度來看，隨著消費者對健康飲品需求的持續增長，大中華即飲軟飲料市場展現出強勁的增長潛力。按零售額計算，其2024年市場規模達1,384億美元，預計將以7.1%的複合年增長率增至2029年的1,947億美元。其中，椰子水飲料作為增長最快的細分領域，預計將以19.4%的複合年增長率從2024年的1,093.3百萬美元增長至2029年的2,651.8百萬美元，市場前景一片光明。IFBH Limited作為行業的領導者，憑藉其強大的品牌影響力、優質的產品品質和完善的銷售網絡，有望持續享受行業增長帶來的紅利。未來，公司將繼續堅持創新驅動，不斷提升產品品質，加強品牌建設，拓展市場份額。同時，不斷加強與合作夥伴的深度合作，實現資源共享、優勢互補，驅動公司業績及股價再上新台階。 Copyright 2025 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

“The Vicissitudes of Life” Celebrates the Transformative Power of Art in Dialogue, Reflection and PeacebuildingPENANG, Malaysia, Sept 17, 2025 - (ACN Newswire via SeaPRwire.com) - Renowned humanitarian-artist Professor Lin Xiang Xiong (“Professor Lin”) and founder of the Lin Xiang Xiong Art Gallery in Penang, presented his latest exhibition, “The Vicissitudes of Life”, at the historic Hôtel de l’Industrie in Paris from 10 to 13 September 2025.(L-R) Jean-Pierre Raffarin, former French Prime Minister and founder of Lin Xiang Xiong Art Gallery, Professor Lin Xiang XiongThe exhibition received strong support from key French institutions, with former French President François Hollande serving as Honorary Patron, and former French Prime Minister Jean-Pierre Raffarin personally attending the opening. Featuring 25 original works by Professor Lin, the exhibition explored three themes - anti-war, anti-poverty, and anti-pollution - and vividly embodied Professor Lin’s vision of “Art for Peace”, a concept that transcends aesthetics and seeks to inspire moral reflection and intercultural understanding.Distinguished speakers exchange views on art, culture, and peace during the academic symposium held as part of Professor Lin Xiang Xiong’s exhibition “The Vicissitudes of Life” in Paris.During the exhibition, a high-level academic symposium was held, bringing together leading international scholars, philosophers, and cultural leaders to reflect on “Intercultural Dialogue at the Crossroads” and “Rebuilding the Concept of Peace through Art.” Distinguished speakers included French writer and human rights activist Marek Halter, eminent philosopher and sinologist François Jullien, intellectual publisher François L’Yvonnet, Swiss curator and sociologist Barbara Polla, special adviser to the President of the Arab World Institute Claude Mollard, cultural diplomacy advisor Yves Marek, and retired French Air Force General Étienne Copel. Throughout the discussions, Professor Lin shared his unique insights on the times, on art, and on the essence of peace, sparking strong resonance and deep dialogue.On 12 September, the inaugural “Lin Xiang Xiong Art for Peace Prize” ceremony was held with great success. The competition drew 1,883 entries from 100 countries around the world, far exceeding expectations. This overwhelming response underscored the wide recognition of Professor Lin’s “Art for Peace” advocacy, echoing the common aspirations of today’s world. Professor Lin announced that the award will be established as a biennial event, continuing as a major artistic initiative dedicated to peace.The exhibition and symposium attracted a full house at the historic Hôtel de l’Industrie in Paris.“This exhibition is more of an awakening of thought than a presentation of art,” said Professor Lin Xiang Xiong. “Every brushstroke is a testimony of time, a silent dialogue between past and present, pain and healing. Whether through the exhibition or the establishment of the Peace Prize, I hope art is not merely for admiration but can truly touch hearts, serve as a bridge between cultures, and awaken the soft conscience deep within humanity.”Exhibition view of “The Vicissitudes of Life”The exhibition also marks a milestone in Professor Lin’s artistic journey and heralds the opening of the Lin Xiang Xiong Art Gallery in Penang, scheduled for mid-December 2025. Covering 8,000 square meters, the gallery will house Professor Lin’s major works and also providing a platform for emerging artists to pursue their dreams. It will stand as one of the largest private art galleries in the region, strengthening Malaysia’s role as a hub of cultural diplomacy and intercultural understanding in Southeast Asia.Through “The Vicissitudes of Life,” Professor Lin once again demonstrates that art is a messenger of thought and conscience. With clarity, he advocates peace, and as an artist, he chooses his own path - through the soft power of culture, through words, and through his brush - to voice his deep concern for war, pollution, and poverty. With art as his language, he calls upon fellow artists to join his cause, uniting their strength to speak out for peace and the future of humanity.Download high-resolution images from this LINK.About Lin Xiang XiongProfessor Lin Xiang Xiong is a renowned artist, entrepreneur, and advocate for global security through art. As President of the Global Chinese Arts & Culture Association, a researcher at the Chinese Academy of Art, and a visiting Professor at Peking University, Lin's work crosses disciplines and borders, connecting Eastern and Western cultures.After leaving China for Singapore in 1956, Lin pursued art studies at the Academy of Arts (1965–1968). Success in business, particularly in the mining industry in Malaysia, funded his travels, art remained his personal refuge and lifelong passion.His painting style is a dynamic combination of abstraction, traditional techniques, and contemporary social commentary, touching on themes such as climate change, war, forced migration, and the human condition. Despite being involved in the commercial field, Lin has never neglected his commitment to art as a force for good.Professor Lin is an outspoken advocate of the power of the arts in promoting peace and unity. In 2016, he curated a UNESCO exhibition titled "Art for Peace – Cultural Dialogue between East and West", which calls on artists to rise up as peacemakers, reduce inequality, and protect the planet. These events resulted in important cultural dialogues that have been documented and archived by UNESCO. Professor Lin has published numerous works, including 8 collections of paintings and 27 volumes of essay and art criticism.For media information, kindly contact:Triven Marketing Group, for Lin Xiang Xiong Art GalleryJazzmin WanTel: +6 017 289 4110Email: j.wan@swanconsultancy.biz Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

Calgary, Canada, Sept 17, 2025 - (ACN Newswire via SeaPRwire.com) - Karbon-X Corp. (OTCQX:KARX) (“Karbon-X" or the “Company”), a vertically integrated climate solutions company, today announced that it has filed its Form 10-K with audited financial results for the fiscal year ended May 31, 2025.The full filing is available under the Company’s profile on OTC Markets at www.otcmarkets.com/stock/KARX/overview  Operational and Strategic highlights for Fiscal Year 2025Completed the acquisition of ALLCOT Group, expanding Karbon-X’s global footprint and integrating world-class expertise.Launched trading operations, marking a critical milestone in validating the Company’s business model and initiating its revenue-generating activities. Entered landmark partnerships with major energy producers and with the BK Dukes, reflecting strong market confidence in Karbon-X’s vision and capabilities.Financial Highlights for Fiscal Year 2025  Revenue surged to $3.16 million, up from $0.41 million in the prior year, marking the first full year of active carbon credit trading.Recognized $3.86 million in deferred revenue from forward carbon credit contracts, including contracts acquired through the ALLCOT transaction.The ALLCOT acquisition expanded Karbon-X’s verified emissions pipeline and positioned the Company for multi-jurisdictional credit monetization. Entered revenue-generating agreements with major energy producers and the BK Dukes, contributing to $3.79 million in receivables from forward carbon credit sales.“2025 was a pivotal year for Karbon-X, marked by the acquisition of ALLCOT Group, the launch of our trading operations, and new partnerships that strengthened our position in the global carbon market. These achievements are reflected in our financial results, which highlight both the momentum we’ve built and the foundation we’ve established for long-term growth. We are confident in our strategy and committed to delivering lasting value for shareholders and the planet.” – Chad Clovis, CEO of Karbon-XLooking AheadThe Company intends to continue to execute on its growth strategy, with a focus on expanding its role in both compliance and voluntary carbon markets, advancing new partnerships, and scaling its portfolio of climate solutions. Management believes Karbon-X is well-positioned to capitalize on increasing demand for trusted climate solutions and to deliver long-term value for shareholders. About Karbon-XKarbon-X Corp. (OTCQX:KARX) is a vertically integrated climate solutions company delivering end-to-end climate solutions across both compliance and voluntary markets. From project origination and emissions quantification to third-party verification, credit issuance, and market distribution, Karbon-X ensures transparency and impact at every step. Karbon-X makes trusted climate action accessible not only to businesses and institutions, but also to individuals and everyday people who want their choices to create lasting impact.Forward Looking Statement This news release contains forward-looking statements, including but not limited to expectations related to Karbon-X Corp.’s financial performance, business strategy, growth plans, and market positioning. These statements are based on current expectations and are subject to risks and uncertainties that could cause actual results to differ materially. Forward-looking statements are subject to change, and Karbon-X Corp. assumes no obligation to update them, except as required by law.Contact: Adriana EbellInterim CFOKarbon-Xa.ebell@karbon-x.com Emma CaputoVP of MarketingKarbon-Xec@karbon-x.com  Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

PHILADELPHIA, PA, Sept 17, 2025 - (ACN Newswire via SeaPRwire.com) - TruMerit, a global leader in healthcare workforce development, today launched two new global credentials for healthcare workers specializing in rehabilitation, habilitation, and restorative care.The Certified Global Health Worker-Rehabilitation (CGHW-R) and the Certified Global Health Worker-Rehabilitation Advanced (CGHW-RA) have been developed specifically for eligible health workers worldwide who wish to have their applied experience and competencies in rehab care recognized and verified by passing a certification examination. These credentials, along with the Certified Global Nurse-Rehabilitation (CGN-R) that TruMerit established last year, are intended to advance and improve services for the more than two billion people worldwide who need this care.The CGHW-RA credential was developed for those with a degree or diploma in a rehabilitation field. These include clinicians, educators, and instructors with physiotherapy, occupational therapy, speech language pathology, or other rehab-related specializations.The CGHW-R credential was designed for those who have rehab health experience but have not completed post-secondary education in an area of rehab specialization. These would include technicians, assistive personnel, nursing assistants, and home or community health aides working in rehabilitation, habilitation, and restorative care settings.In addition to education and degree requirements, candidates for these credentials must have at least two years of work experience in a rehabilitation, habilitation, or restorative care setting during the last five years. Upon verification of their credentials by TruMerit, they must pass a proctored exam that is offered at more than 1,000 test centers worldwide.In 2019, CARF International, a non-profit organization that accredits rehabilitation care providers worldwide, alerted TruMerit (known then as CGFNS International) about the growing demand for validating practice competence of the rehabilitation health workforce and raising standards across the care continuum. TruMerit and rehabilitation experts from across the world began the process to create exam-based global certifications for healthcare professionals working in rehabilitation, habilitation, and restorative care settings. The process has included more than 200 subject matter experts from 45 countries from all world regions and income levels."Caring for the huge and growing population of persons living with a disability is one of the most pressing issues facing healthcare today. By validating the knowledge and skills of those who devote their careers to providing this care, global credentials will help drive efforts to expand and equip this vital workforce to meet the challenges of the future. We are grateful to the global team of rehab care experts who helped make these credentials possible," said Julia To Dutka, Chief of TruMerit's Global Health Workforce Development Institute, which is leading the initiative.View more information on TruMerit's global rehab certification program.Additionally, last month TruMerit unveiled its Certified Global Nurse (CGN) credential for first-level, general nurses (RNs), along with a reinvented Nurse Qualifying Exam.About TruMeritTruMerit is a worldwide leader in healthcare workforce development. Formerly known as CGFNS International, the organization has a nearly 50-year history supporting the career mobility of nurses and other healthcare workers-and those who license and hire them-by validating their education, skills, and experience as they seek authorization to practice in the United States and other countries. As TruMerit, this mission has been expanded to building workforce capacity that meets the needs of people in a rapidly evolving global health landscape. Through its Global Health Workforce Development Institute, the organization is advancing evidence-based research, thought leadership, and advocacy in support of healthcare workforce development solutions, including globally recognized practice standards and certifications that will enhance career pathways for healthcare workers.Contact InformationDavid St. Johndstjohn@trumerit.orgSOURCE: TruMerit Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HONG KONG, Sep 17, 2025 - (ACN Newswire via SeaPRwire.com) – HighTide Therapeutics, Inc. (2511.HK), a clinical stage biopharmaceutical company specializing in the development of multifunctional multi-targeted therapies for metabolic diseases, announced that data from the Phase 3 SYMPHONY 2 trial evaluating the safety and efficacy of HTD1801 in patients with type 2 diabetes mellitus (T2DM) is being presented at the 61st Annual Meeting of the European Association for the Study of Diabetes (EASD) in Vienna.HTD1801, is a first-in-class anti-inflammatory metabolic modulator that activates AMPK and inhibits the NLRP3 inflammasome. These pathways converge at the nexus of metabolic dysregulation beyond glucose control and chronic inflammation. This randomized, double-blind, placebo-controlled study evaluated the efficacy and safety of HTD1801 compared to placebo in patients with T2DM inadequately controlled with metformin. The primary endpoint of Symphony 2 was change from baseline in HbA1c to Week 24 compared to placebo. Secondary endpoints explored effects on cardiovascular, metabolic, and renal comorbidities to assess it’s potential as a comprehensive Cardiovascular-Kidney-Metabolic therapy.Eligible patients were randomized 2:1 to HTD1801 1000 mg BID (N=365) or placebo (N=184). The study met the primary endpoint at Week 24, with HTD1801-treated patients achieving an LS mean change in HbA1c of -1.21% compared to -0.68% with placebo (LS mean diff: -0.53, p<0.0001). 33% of HTD1801-treated patients achieved HbA1c <7% at Week 24 vs 11% with placebo (p<0.0001). Improvements in HbA1c with HTD1801 were parallelled with significant improvements in postprandial and fasting glucose at Week 24. In patients with mild renal impairment, HTD1801 improved eGFR, suggesting reno-protective potential. Significant reductions in lipids and inflammatory markers were also observed with HTD1801. Safety and tolerability were favorable and consistent with previous clinical trials of HTD1801. Serious AEs occurred in 4% vs 6% of patients with HTD1801 vs placebo, respectively. No patient experienced severe hypoglycemia during the study. An open-label extension is ongoing to confirm the durability of these benefits of HTD1801.Abstract Title: Symphony 2: A Randomized, Placebo-Controlled Phase 3 Study of Berberine Ursodeoxycholate in Patients with Type 2 Diabetes Inadequately Controlled with MetforminPresentation Number: 62Presentation Date/Time: Tuesday September 16, 2025 / 2:45pm CESTFormat: Oral PresentationPresenting Author: Linong Ji“HTD1801 is an innovative small-molecule drug with a novel dual mechanism of action, simultaneously activating AMPK and inhibiting the NLRP3 inflammasome.”said professor Linong Ji, the leading principal investigator for this Phase 3 clinical trial and former Vice President of the International Diabetes Federation (IDF), Director of the Peking University Diabetes Center and Director of the Department of Endocrinology and Metabolism, Peking University People’s Hospital, “In completed Phase 3 clinical trials, it demonstrated consistent and clinically meaningful glucose-lowering effects with a favorable safety profile. Beyond glycemic control, HTD1801 has also shown multiple additional benefits, including lipid reduction, attenuation of inflammation, and improvements in renal function. As an orally administered antidiabetic agent, HTD1801 uniquely provides both cardiometabolic risk factor modification and renal protection, underscoring its substantial potential and competitive advantage for further clinical development.”“The SYMPHONY 2 trial is our second Phase 3 study in type 2 diabetes to achieve its primary endpoint, underscoring the consistency and robustness of HTD1801’s clinical profile,” said Liping Liu, Founder, Chairwoman and CEO of HighTide Therapeutics. “We are particularly pleased that HTD1801 demonstrated not only glycemic benefit but potential cardiovascular and renal benefit in T2DM patients. With successful Phase 3 trials now in hand, we are well-positioned to submit our NDA in China later this year – marking a major step toward bringing a novel therapy to millions of patients who continue to face significant unmet needs in diabetes care.”About HTD1801HTD1801 is a first-in-class new molecular entity, addressing the residual risks of cardiovascular-kidney-metabolic (CKM) diseases. HTD1801 is an orally delivered, anti-inflammatory metabolic modulator that, as a single molecular entity, exhibits a unique dual mechanism of action through AMPK activation and NLRP3 inflammasome inhibition, both pathways working to mitigate dysfunctions associated with metabolic diseases. Multiple global clinical trial results have demonstrated comprehensive benefits of HTD1801, including improved insulin resistance, glycemic control, lipid lowering, renal benefit, weight loss, hepatic benefits, and anti-inflammatory effects. Therefore, HTD1801 has the potential to become a foundational CKM therapy.About HighTide TherapeuticsHighTide Therapeutics, Inc. (2511.HK) is an innovative biopharmaceutical company specializing in metabolic diseases. The company is dedicated to developing first-in-class breakthrough therapies, providing therapeutic solutions with comprehensive benefits for patients worldwide. HighTide Therapeutics has established a globally positioned product pipeline with 100% self-developed intellectual property. The company has conducted clinical studies for multiple indications across various countries and regions, and the outcomes of these studies have been well recognized by global academic community and regulatory bodies worldwide. HTD1801, HighTide Therapeutics’ lead asset, is a first-in-class dual-target new molecular entity. It has received two Fast Track designations and one Orphan Drug designation from the US Food and Drug Administration (FDA), and has been included twice in the National Major Science and Technology Project for Significant New Drug Development in China.For more information, please visit www.hightidetx.com, Contact: pr@hightidetx.com Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

香港，2025年9月17日 - (亞太商訊 via SeaPRwire.com) - 君聖泰醫藥（股票代碼: 2511.HK），一家專注於開發多功能療法以解決代謝性疾病未滿足臨床需求的創新藥公司，宣布在第61屆歐洲糖尿病研究協會（EASD）年會（奧地利維也納），口頭報告2型糖尿病（T2DM）患者中評估HTD1801有效性和安全性的3期臨床研究（SYMPHONY 2）數據。HTD1801是全球首創抗炎代謝調節劑，通過激活AMPK並抑制NLRP3炎症小體的雙重作用機制，為患者帶來遠超血糖控制的綜合性代謝獲益。這項隨機雙盲、安慰劑對照的臨床研究旨在評估HTD1801與安慰劑相比在二甲雙胍控制不佳的T2DM患者中的有效性和安全性。SYMPHONY 2的主要終點為與安慰劑相比治療24周後HbA1c相對於基線的變化。次要終點包括對心血管、代謝及腎臟共病的危險因素干預，以評估HTD1801作為心腎代謝系統疾病（CKM）的綜合治療潛力。SYMPHONY 2試驗中，患者按2:1隨機分配至HTD1801組（1000mg一天兩次，N=365）或安慰劑組（N=184）。該研究達到了主要終點，HTD1801治療組第24周HbA1c的最小二乘（LS）均值變化為 -1.21%，安慰劑組為-0.68%（LS均值差異：-0.53%， p＜0.0001）。33%的患者在HTD1801治療24周後達到HbA1c＜7%的控制目標，安慰劑組僅有11%（p＜0.0001）。治療24周後，HTD1801還顯著改善了餐後血糖和空腹血糖。事後分析顯示在合併輕度腎損的患者中，HTD1801可改善eGFR，提示腎臟保護的潛力。此外，HTD1801顯著降低了預設次級終點中血脂和炎症標誌物。與之前臨床研究結果一致，HTD1801表現出良好的安全性和耐受性。HTD1801組的嚴重不良反應發生率為4%，安慰劑組為6%。研究期間未發生嚴重低血糖事件。該研究對應的開放標籤延長期試驗正在進行中，將進一步驗證HTD1801綜合療效的持久性。 摘要標題：Symphony 2：一項評估HTD1801治療二甲雙胍控制不佳的2型糖尿病患者的隨機、安慰劑對照的臨床3期研究報告編號：62報告時間：2025年9月16日，周二，下午2:45（歐洲中部夏令時）報告形式：口頭報告演講者：紀立農 教授臨床試驗的主要研究者，前國際糖尿病聯盟（IDF）副主席、北京大學糖尿病中心主任、北京大學人民醫院內分泌和代謝科主任紀立農教授指出：「HTD1801 是一款具有源頭創新性的小分子藥物，具有獨特的雙重作用機制，能夠同時激活 AMPK和抑制 NLRP3 炎症小體。在已經完成的3期臨床研究中，該藥物展現出非常平穩且顯著的降糖效果而且安全性良好。除此之外，研究還觀察到 HTD1801 具有降糖之外的多重獲益，包括降低血脂水平、減輕炎症反應，以及改善腎臟功能等相關指標。作為一種口服降糖藥物，HTD1801 在改善心血管危險因素與保護腎臟功能方面也展現出潛力，值得進一步探索其在心腎保護方面的潛力」君聖泰醫藥的創始人、董事長兼首席執行官劉利平博士表示：「SYMPHONY 2是我們在2型糖尿病領域開展的第二項3期臨床研究，已成功達到主要臨床終點，充分表明HTD1801臨床療效的一致性和可靠性。值得關注的是，HTD1801不僅展現出顯著的血糖獲益，同時在心血管和腎臟方面亦為T2DM患者帶來潛在獲益。隨着3期臨床試驗的順利進行，我們今年將在中國遞交NDA申請，為廣大糖尿病患者帶來新的治療選擇，填補該疾病領域創新療法重大未滿足需求。」關於HTD1801HTD1801是一款全球首創的新分子實體，旨在解決心腎代謝系統疾病（CKM）。HTD1801是口服抗炎及代謝調節劑，作為單一分子具有獨特雙機制 ，通過激活AMPK及抑制NLRP3炎症小體發揮其生物學活性，有效解決代謝性疾病。全球多項臨床結果驗證HTD1801一藥多效的特性，為患者帶來綜合獲益，包括改善胰島素抵抗、血糖控制、血脂降低、腎臟獲益、體重減輕、肝臟獲益及抗炎等。基於此，HTD1801有潛力成為CKM領域的基礎性治療藥物。關於君聖泰醫藥君聖泰醫藥（股票代碼：2511.HK）是一家專注於代謝性疾病的創新生物醫藥公司。立足源頭創新，公司致力於開發代謝性疾病的突破性療法，為全球患者提供標本兼治、綜合獲益的解決方案。公司已建立100%自主知識產權的全球化產品管線，已在多個國家和地區開展了針對多項適應症的臨床研究，相關成果獲得國際學術界和監管機構的認可。公司核心產品HTD1801是全球首創的雙靶點新分子實體，已獲得美國食品藥品監督管理局（FDA）2項快速通道與1項孤兒藥資格認定、以及2項「重大新藥創製」國家科技重大專項。 更多信息，請訪問公司官網：www.hightidetx.com， 或聯繫公司品牌部: pr@hightidetx.com Copyright 2025 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

SAN DIEGO, Sept 17, 2025 - (ACN Newswire via SeaPRwire.com) - General Atomics Aeronautical Systems, Inc. (GA-ASI), in collaboration with the Dutch Ministry of Defence and the Dutch Ministry of Economic Affairs, will host its second Blue Magic Netherlands (BMNL) event on November 18, 2025. BMNL 2025 follows the successful first event in 2024 and will take place at the MELT at Avular building, a world-class venue for technology interchange near Brainport Eindhoven, the center of the Dutch high-technology manufacturing industry. The registration site can be accessed at www.ga-asi.com/blue-magic-netherlands-2025."The first BMNL event was a huge success for Dutch industry," said Brad Lunn, managing director for GA-ASI. "We've built strong investment opportunities with Dutch companies - including Arceon, Emergent Swarm Solutions, and Saluqi Motors - and now we're looking to build on that success at BMNL 2025."Blue Magic Netherlands fosters technology ideation and implementation within the Dutch industrial ecosystem. GA-ASI is inviting Netherlands-based technology and aerospace companies, big and small, to apply for a chance to pitch transformative next-gen solutions that could shape the course of commercial and defence technologies. This event brings together leaders in advanced technology, aerospace, business, and government in a single Dutch forum to explore emerging technologies that address the world's most pressing defence and security challenges. GA-ASI supplies its MQ-9A Remotely Piloted Aircraft to the Royal Netherlands Air Force.Along with partners Brainport Development Eindhoven, Lockheed Martin Ventures, Brabant Development Agency and the Netherlands Industries for Defence & Security (NIDV), GA-ASI will accept proposals to present a broad range of technologies. Participating in this transformational event provides an ideal opportunity to connect with funding sources and collaborate with industry leaders. Companies and individuals wishing to only join the audience and network are welcome to register as well.Companies interested in presenting their capabilities can submit a pitch proposal. GA-ASI and other participants will hear technology pitches followed by a lively panel discussion. Networking opportunities will also be available where participants can meet with other high-tech businesses and industry leaders to see if their capabilities can be leveraged in new and useful ways. Focus areas for this year are Intelligent Systems - Artificial Intelligence (AI)/Machine Learning and Autonomy, Smart Materials - Advanced Materials and Manufacturing, Sensors, Space, and Counter-UAS.Companies interested in presenting their capabilities must submit pitch proposals in PDF format by no later than October 10, 2025. Companies selected to present pitches will be notified on November 3, 2025.To submit a pitch proposal or register to attend in person or virtually, please visit the event website at www.ga-asi.com/blue-magic-netherlands-2025.BMNL organizers will also host several virtual workshops covering a variety of topics relevant to defence technology start-ups. These workshops will be listed on the event website and are available for the entire Dutch innovation ecosystem.About GA-ASIGeneral Atomics Aeronautical Systems, Inc., is the world's foremost builder of Unmanned Aircraft Systems (UAS). Logging more than 8 million flight hours, the Predator® line of UAS has flown for over 30 years and includes MQ-9A Reaper®, MQ-1C Gray Eagle®, MQ-20 Avenger®, and MQ-9B SkyGuardian®/SeaGuardian®. The company is dedicated to providing long-endurance, multi-mission solutions that deliver persistent situational awareness and rapid strike.For more information, visit www.ga-asi.com.Avenger, EagleEye, Gray Eagle, Lynx, Predator, Reaper, SeaGuardian, and SkyGuardian are trademarks of General Atomics Aeronautical Systems, Inc., registered in the United States and/or other countries.Contact InformationGA-ASI Media Relationsasi-mediarelations@ga-asi.com(858) 524-8101SOURCE: General Atomics Aeronautical Systems, Inc. Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

香港，2025年9月16日 - (亞太商訊 via SeaPRwire.com) - 傳統醫藥產業與鏈上金融的深度融合，正為全球非處方藥資產開啟一扇數位化、全球化的價值之門。9月16日，華檢醫療（01931.HK）發佈公告宣佈，公司與仁和藥業（000650.SZ）之間接全資附屬公司仁和國際達成戰略合作，共同於美國籌建全球首個專注於非處方藥（OTC）領域的垂直RWA交易所。華檢醫療9月16日發佈之公告此舉是華檢醫療「ETHK鏈上金融生態戰略」及「全球RWA交易·所中所」商業模式成功落地的關鍵第一步與標杆案例，旨在打造一個可規模複製的樣板，驗證該創新模式的可行性及巨大潛力。一、強強聯合，構建全球OTC RWA交易新生態華檢醫療與仁和藥業的合作代表了傳統產業與金融科技的創新融合。仁和藥業作為中國非處方藥物（OTC）協會會長單位，在中國OTC市場擁有極具競爭力的穩固份額和廣泛的行業號召力。而華檢醫療則依託其前瞻性的技術佈局，構建了覆蓋區塊鏈底層架構、智慧合約開發、資產數位化發行及流通結算的全棧式技術解決方案。此次合作將充分發揮雙方獨特優勢。仁和藥業將其在中國市場無與倫比的線下管道網絡及線上行銷能力與華檢醫療提供的全球合規技術架構相結合，產生強大的"乘法效應"。這種"中國領先管道網絡+全球合規數位化平台"的獨特組合，構成了難以被競爭對手複製的核心競爭壁壘。二、創新模式，破解RWA發展核心瓶頸長期以來，RWA的巨大潛力始終受限於幾大核心瓶頸：公鏈性能的限制、傳統與加密世界的資金壁壘、複雜的跨境監管以及普遍存在的流動性不足等問題。華檢醫療通過創新的「所中所」商業模式，為各行業龍頭企業提供頂尖的技術基礎設施與合規運營支援。這種模式使其能夠以輕資產方式運行，通過與行業龍頭合作快速切入不同領域，具備極強的可複製性和規模化擴張潛力。華檢醫療「ETHK全球RWA交易·所中所」戰略模式之核心運作邏輯如下：賦能核心資產端（聚合優質資產源）：依託本集團在全球RWA交易所技術生態及創新金融科技應用領域的深厚積澱，為各行業領域中擁有核心資產且具備代幣化需求的上市公司，量身定制並共同搭建其垂直行業領域專屬RWA交易所。通過提供資產篩選、結構設計、合規發行與流動性管理的一站式解決方案，助力合作企業實現資產數位化轉型，優化資本結構，拓展全球戰略佈局，最終推動產業升級與價值重塑。對接核心資本端（構建全球流動性網絡）：致力於為全球知名的銀行、基金、信託公司等持牌金融機構，提供安全、高效、合規的全球RWA資產配置通道與數位化交易解決方案。通過構建多層次、國際化的資本接入體系，滙聚全球頂級投資機構的專業資本與流動性，深度參與RWA資產的定價、流通與價值重構，提升全球資產配置效率。生態協同與連結：本戰略的核心在於聯合與連結全球各個生態領域的上市公司（核心資產方）和金融機構（核心資金方），共築鏈上金融新生態。本集團依託「ETHK」品牌生態，分別從鏈上金融基礎設施技術服務能力（由ETHK Labs及/或旗下專業主體提供）與鏈上金融全球合規運營支援（由ETHK Inc等附屬公司提供）兩大層面，為合作方提供堅實後盾，深化「ETHK全球RWA交易·所中所」戰略的構建與落實。此次合作的OTC垂直領域RWA交易所將實現多項創新突破：支持多鏈部署、支持法幣與穩定幣雙通道申贖、通過自研智慧合約提供即時贖回功能。這些技術創新有效地解決了RWA領域的監管合規、跨鏈操作及流動性問題，為傳統金融資產上鏈提供了可複製的解決方案。三、雙向賦能，開啟全球OTC市場新紀元該OTC RWA交易所將構建一個雙向暢通的全球化資本與產品流通管道。一方面推動中國資產出海：平台將助力仁和藥業及其關聯的中國優秀OTC企業，將其智慧財產權資產通過RWA代幣化的方式進行結構性重塑，並面向全球專業及機構投資者進行融資與流通。另一方面引進全球高科技資產：積極引入美國、日本等OTC產業發達地區的創新、高端產品與技術，例如美國以"Hims & Hers"為代表的直接面向消費者（DTC）健康科技模式下的創新產品，以及來自日本的頂尖酵素產品、功能性化妝品和功能性食品等。這種雙向流動不僅有利於中國OTC企業獲取全球資本認可，也為國內消費者引入了全球最前沿的健康科技成果，滿足日益升級的健康與美麗需求。四、利國利民，ETHK生態戰略的重大進展華檢醫療此次與仁和藥業的戰略合作，是其「ETHK鏈上金融生態戰略」落地的關鍵里程碑。ETHK生態旨在通過科技賦能，打造一個安全、高效、合規、開放的去中心化金融平台，通過技術創新與生態整合，構建定義未來金融格局的全球鏈上金融生態王國。本項目深度助力中國OTC產業的數位化升級與全球化拓展，通過引入國際先進的產品、技術及管理經驗，切實推動"健康中國"戰略的落地。它不僅能夠加速國內大健康產業的供給側改革，更能滿足中國人民對更高品質、多元化健康生活日益增長的需求。對於全球OTC產業而言，此次合作將首創"數字License-in/Out"模式，極大破除傳統跨境合作的壁壘，提升全球OTC產業在研發、融資、流通全鏈條的創新效率與資源整合速度，有望重新定義行業規則與合作標準。五、前景廣闊，RWA市場迎來爆發式增長據Defillama資料，截至2025年6月，RWA總鎖倉量（TVL）達125億美元，較2024年增長124%。波士頓諮詢公司（BCG）與新加坡數字證券交易所（ADDX）聯合預測，到2030年，全球RWA市場規模將達到16.1萬億美元，佔全球GDP的10%。在醫療健康領域，RWA應用正在加速落地。2025年8月，美年健康（002044.SZ）宣佈與國富量子（00290.HK）、京北方（002987.SZ）簽署《數字資產業務合作框架協議書》，三方將依託各自資源稟賦，在數字資產RWA領域開展全方位業務探索與合作。本月初，華檢醫療披露推進收購國富量子20.31%股權事宜，成為其第一大股東，將充分利用其金融牌照與RWA實踐經驗，增強鏈上金融佈局。華檢醫療與仁和藥業的合作，為RWA在垂直領域的深度應用提供了創新範例，展示了鏈上金融與傳統產業融合的巨大潛力。全球RWA市場正在經歷爆發式增長，據CoinGecko資料，所有現實世界資產代幣的市值已達到660億美元。華檢醫療與仁和藥業的合作，為傳統醫藥產業擁抱鏈上金融提供了創新範例，也為中國優質資產對接全球資本開闢了新通道。隨著香港《數字資產發展政策宣言2.0》的深入推進和全球監管框架的逐步完善，RWA有望成為連接傳統金融與數字經濟的橋樑，為產業發展注入新動能。 Copyright 2025 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

德國柏林和佛羅里達州西棕櫚灘, 2025年9月16日 - (亞太商訊 via SeaPRwire.com) - U.S. Polo Assn 作為美國馬球協會（USPA）的官方運動品牌，榮幸地成為 Engel & Völkers 柏林 Maifeld 馬球盃（亦稱 2025 年德國高水平馬球錦標賽）的官方球衣及服裝贊助商。該賽事於 2025 年 8 月 22 日至 31 日在柏林舉行。這一享有盛譽的錦標賽是德國馬球賽季的巔峰，也是歐洲最受矚目的馬球盛事之一。Engel & Völkers 柏林 Maifeld 馬球盃冠軍(照片來源: Guadalupe Aizaga)本屆 Engel & Völkers 柏林 Maifeld 馬球盃的決賽週末在標誌性的 Maifeld 體育場舉行。該場地正是馬球運動上一次在 1936 年奧運會中亮相的歷史性場館。預選賽於 8 月 21 日至 28 日在普魯士馬球鄉村俱樂部舉行，最終迎來了一場精彩的決賽，充分展現了這項運動的最高水平。在緊張激烈的決賽中，Plusquadrat 隊以 7 比 6.5 的比分險勝 Netjets 隊。本屆錦標賽的最有價值球員（MVP）由 Plusquadrat 隊的 Bartolomé Bayugar 獲得，他在決賽中攻入三球，成為全場最佳射手。“作為 Engel & Völkers 柏林 Maifeld 馬球盃的官方球衣及服裝贊助商，對 U.S. Polo Assn. 來說是非同尋常的榮譽，因為這一賽事既彰顯了馬球運動的悠久傳統，也展現了其光明未來。” U.S. Polo Assn. 品牌管理公司 USPA Global 總裁兼首席執行官 J. Michael Prince 表示：“能夠在柏林市中心支持這樣一項歷史悠久的錦標賽，並且是在 1936 年馬球創造奧運歷史的同一片場地上，充分體現了我們這一全球品牌與馬球運動之間真實而深厚的聯繫。”作為賽事的官方球衣及服裝贊助商，U.S. Polo Assn. 為球員和官員提供了品牌性能隊服、裁判球衣、帽子和連帽衫。今年是 U.S. Polo Assn. 連續第六年支持 Engel & Völkers 柏林 Maifeld 馬球盃。該品牌的參與與其更廣泛的歐洲擴張戰略相契合，包括在德國的零售業務增長，以及近年來在英國、意大利、西班牙等市場開展的高影響力推廣活動。今年夏初，U.S. Polo Assn. 慶祝了其在柏林首家零售門店的盛大開業，該門店位於標誌性的 Alexa Mall。這一零售首秀標誌著該品牌在德國及周邊地區與戰略合作夥伴 Incom S.p.a. 和 Modevertrieb Sarnacchiaro GmbH（MVS）共同實施多年的增長戰略的開始，進一步鞏固了 U.S. Polo Assn. 的全球影響力。“我們很高興能繼續與 U.S. Polo Assn. 加深合作，並在每一年不斷提升 Engel & Völkers 柏林 Maifeld 馬球盃的影響力。” Engel & Völkers 柏林 Maifeld 馬球盃賽事主辦方 Sevendays Polo Event GmbH 的聯席首席執行官 Mortiz Gaedeke 表示：“隨著 U.S. Polo Assn. 在德國的不斷擴張，包括其在柏林新開的零售店，此次合作進一步鞏固了馬球運動與他們在體育迷和消費者群體中真實聯繫之間的紐帶。”圖片來源：Guadalupe Aizaga關於 U.S. Polo Assn. 和 USPA Global U.S. Polo Assn. 為美國馬球協會（USPA）之官方品牌，該協會創立於 1890 年，是北美最大馬球俱樂部與馬球運動員聯盟。今年，U.S. Polo Assn. 與美國馬球協會（USPA）共同慶祝品牌成立 135 週年，持續從體育汲取靈感。 U.S. Polo Assn. 擁有數十億美元的全球品牌價值，並透過逾 1,100 間品牌零售店及數千個銷售據點，在全球超過 190 個國家提供男裝、女裝、童裝、配件與鞋類產品。透過與美國 ESPN、歐洲的TNT和印度 Star Sports 的歷史性協議，U.S. Polo Assn. 贊助的多項世界頂級馬球賽事首次轉播至全球數百萬體育迷，讓這項激動人心的運動登上世界舞台。據《License Global》報導，U.S. Polo Assn. 長期被評為全球頂尖體育授權品牌之一，與 NFL、PGA Tour 和 Formula 1 並列。此外，該品牌亦因於全球及數位市場的成長，獲得多項國際獎項肯定。 U.S. Polo Assn. 曾登上《富比士》、《財富》、《現代零售》和《GQ》等主流媒體，也多次出現在 Yahoo Finance 與 Bloomberg 等財經平台。欲了解更多資訊，請造訪 uspoloassnglobal.com 並追蹤 @uspoloassn。USPA Global 為 USPA 子公司，負責營運全球價值數十億美元之 U.S. Polo Assn. 品牌。USPA Global 亦營運提供體育與生活風格內容的 Global Polo TV。要了解更多信息，請訪問 globalpolo.com 或在 YouTube 上搜索 Global Polo。聯繫信息Shannon StilsonVP, Sports Marketing and Media sstilson@uspagl.com+001.561.227.6994Stacey KovalskyVP, Global PR and Communications skovalsky@uspagl.com+001.561.790.8036來源: U.S. Polo Assn. Copyright 2025 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com

BERLIN, GERMANY AND WEST PALM BEACH, FL, Sept 16, 2025 - (ACN Newswire via SeaPRwire.com) - U.S. Polo Assn., the official sports brand of the United States Polo Association (USPA), proudly partnered as the Official Jersey and Apparel Sponsor of the Engel & Völkers Berlin Maifeld Polo Cup, also known as the German High-Goal Championship 2025, held August 22-31, 2025, in Berlin. This prestigious tournament is the pinnacle of the polo season in Germany and is one of the most celebrated events in European polo.Engel & Völkers Berlin Maifeld Polo Cup Winners (Photo Credit: Guadalupe Aizaga)The finals weekend for the Engel & Völkers Berlin Maifeld Polo Cup took place at the iconic Maifeld Stadium, the same historic venue where the sport of polo was last played in the 1936 Olympic Games. Qualifying matches were held August 21-28 at the Prussian Polo and Country Club, leading to a thrilling finale that showcased the very best of the sport. In a dramatic final, Team Plusquadrat pulled away from Team Netjets with a score of 7 - 6.5. The tournament MVP was Bartolomé Bayugar from Team Plusquadrat, who was the top scorer in the final with three goals."Serving as the Official Jersey and Apparel Sponsor for the Engel & Völkers Berlin Maifeld Polo Cup is an extraordinary honor for U.S. Polo Assn. to support an event that celebrates both the rich tradition and bright future of the sport of polo," said J. Michael Prince, President and CEO of USPA Global, the company that manages the multi-billion-dollar U.S. Polo Assn. brand. "To support such an historic tournament in the heart of Berlin, on the same field where the sport made Olympic history in 1936, is a true reflection of our global brand's authentic connection to the sport."As the event's Official Jersey and Apparel Sponsor, U.S. Polo Assn. outfitted players and officials with branded performance team jerseys, umpire jerseys, caps, and hoodies. This year marked U.S. Polo Assn.'s sixth consecutive year supporting the Engel & Völkers Berlin Maifeld Polo Cup.The brand's presence aligns with its broader European expansion, including retail growth in Germany and recent high-impact activations in markets such as the U.K., Italy, Spain, and beyond. Earlier this summer, U.S. Polo Assn. celebrated the grand opening of its first retail store in Berlin, located at the iconic Alexa Mall. This retail debut marks the beginning of a multi-year growth strategy across Germany and surrounding regions with strategic brand partners Incom S.p.a. and Modevertrieb Sarnacchiaro GmbH (MVS), further solidifying U.S. Polo Assn.'s presence globally."We are excited to continue building our partnership with U.S. Polo Assn. as we elevate the Engel & Völkers Berlin Maifeld Polo Cup year after year," said Mortiz Gaedeke, Co-CEO of Sevendays Polo Event GmbH, the Engel & Völkers Berlin Maifeld Polo Cup event organizer. "With U.S. Polo Assn.'s growing presence in Germany, including their new Berlin retail store, this collaboration strengthens the link between the sport of polo and their authentic connection with sports fans and consumers."Photo Credit: Guadalupe AizagaAbout U.S. Polo Assn. and USPA GlobalU.S. Polo Assn. is the official sports brand of the United States Polo Association (USPA), the largest association of polo clubs and polo players in the United States, founded in 1890 and based at the USPA National Polo Center (NPC) in Wellington, Florida. This year, U.S. Polo Assn. celebrates 135 years of sports inspiration alongside the USPA. With a multi-billion-dollar global footprint and worldwide distribution through more than 1,100 U.S. Polo Assn. retail stores as well as thousands of additional points of distribution, U.S. Polo Assn. offers apparel, accessories, and footwear for men, women, and children in more than 190 countries worldwide. The brand sponsors major polo events around the world, including the U.S. Open Polo Championship®, held annually at NPC in The Palm Beaches, the premier polo tournament in the United States. Historic deals with ESPN in the United States, TNT and Eurosport in Europe, and Star Sports in India now broadcast several of the premier polo championships in the world, sponsored by U.S. Polo Assn., making the thrilling sport accessible to millions of sports fans globally for the very first time.U.S. Polo Assn. has consistently been named one of the top global sports licensors in the world alongside the NFL, PGA Tour, and Formula 1, according to License Global. In addition, the sport-inspired brand is being recognized internationally with awards for global growth. Due to its tremendous success as a global brand, U.S. Polo Assn. has been featured in Forbes, Fortune, Modern Retail, and GQ as well as on Yahoo Finance and Bloomberg, among many other noteworthy media sources around the world.For more information, visit uspoloassnglobal.com and follow @uspoloassn.USPA Global is a subsidiary of the United States Polo Association (USPA) and manages the multi-billion-dollar sports brand, U.S. Polo Assn. USPA Global also manages the subsidiary, Global Polo, which is the worldwide leader in polo sport content. To learn more, visit globalpolo.com or Global Polo on YouTube.Contact InformationShannon StilsonVP, Sports Marketing and Mediasstilson@uspagl.com+001.561.227.6994Stacey KovalskyVP, Global PR and Communicationsskovalsky@uspagl.com+001.561.790.8036SOURCE: U.S. Polo Assn. Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

4-day programme to feature exhibition, business matching programmes and dialogue sessions.KUALA LUMPUR, Sept 16, 2025 - (ACN Newswire via SeaPRwire.com) - The Malaysia International Halal Showcase (MIHAS) returns for its 21st edition at the Malaysia International Trade and Exhibition Centre (MITEC), Kuala Lumpur, from 17 to 20 September 2025. Recognised as a significant platform for the halal sector, MIHAS 2025, themed "Pinnacle of Halal Excellence", will see the participation of 45,000 visitors, 2,400 booths as well as exhibitors and buyers from 80 countries. The four day event will provide global  businesses, policymakers, and industry thought leaders opportunities for deals, dialogues, and collaboration through its multiple components including exhibition, incoming specialised buying mission (INSP), Knowledge Hub seminars and Awards ceremony.On 19 September, the Prime Minister of Malaysia, YAB Dato’ Seri Anwar Ibrahim, will officiate the opening ceremony. MIHAS 2025 serves as the trade component of the Global Halal Summit (GHaS), underlining Malaysia’s commitment to advancing standards, innovation, and transnational partnerships as the halal sector develops further.Exhibition and Visitor ParticipationThis year's MIHAS invites trade visitors to a well-curated exhibition space highlighting halal food and beverage, pharmaceuticals, medical devices, Islamic finance, fashion and lifestyle products, personal care, cosmetics, and Muslim-friendly tourism. Pavilions from both local and international representatives, government agencies, and leading industry participants demonstrate the broad scope of the global halal market.Business Matching and Market AccessThe International Sourcing Programme (INSP) remains integral to this year’s showcase, supporting targeted business connections and exploration of new markets. Trade visitors and participating companies will be able to access platforms, including MADANI Digital Trade, to facilitate purposeful meetings with buyers and sellers, enabling direct engagements that may lead to mutually beneficial export developments.Knowledge Hub and Industry DialogueThe Knowledge Hub continues to provide delegates with expert briefings, industry-focused panel discussions, and Power Talks. These sessions aim to offer guidance on halal certification and market access, as well as discussions around current themes facing the global sector, such as digitalisation and sustainability. Companies and delegates are encouraged to participate in these events to gain market intelligence and strengthen their professional networks.Recognising Industry Excellence and ContributionThe MIHAS Awards Ceremony will take place on 20 September to recognise enterprises demonstrating quality, strategic vision, and responsible leadership. The Excellence Awards and Innovation and Sustainability Awards affirm MIHAS’ commitment to encouraging best practices and progress throughout the sector.International PerspectivesMIHAS continues to broaden its reach with the expansion of its international editions. Following the success of MIHAS in Dubai in 2024, this year introduces MIHAS@Shanghai, held from 5 to 10 November in conjunction with the China International Import Expo (CIIE). Malaysian enterprises will benefit from a dedicated platform to present their products and services to the Chinese market, one of the world’s largest and fastest-growing halal consumer bases. Through responsible partnerships and bilateral cooperation, exemplified by a Memorandum of Understanding (MoU) between MATRADE and the CIIE Bureau, MIHAS@Shanghai enables participating companies to strengthen their global competitiveness and build lasting business connections with buyers across East Asia and the wider region.Join Us at MIHAS 2025Secure your place among industry leaders and innovators. Register now to participate as a trade visitor, exhibitor, or delegate; schedule your business meetings, attend Power Talks, and position your enterprise for lasting success in the global halal economy. Discover the opportunities awaiting you at MIHAS 2025 and advance your business.Connect with the MIHAS 2025 Secretariat at Malaysia International Halal Showcase or visit the MIHAS 2025 website for further details and registration procedures.ABOUT MALAYSIA INTERNATIONAL HALAL SHOWCASE (MIHAS) 2025Since its inception in 2004, the Malaysia International Halal Showcase (MIHAS) has evolved into a pivotal event for both local and international businesses to flourish within the Halal trade, significantly contributing to the global Halal economy’s expansion. In 2024, MIHAS set a new benchmark by recording sales of RM4.3 billion. This achievement not only underscores MIHAS’s stature as a premier global trade platform for the Halal industry but also highlights its role in driving the sector's growth and innovation.MIHAS has established itself as a dynamic marketplace, offering a broad spectrum of opportunities that extend beyond Halal food. It encompasses sectors such as Halal pharmaceuticals, medical devices, finance, modest fashion, personal care and cosmetics, and even Muslim-friendly tourism. This diversity reflects the evolving nature of the Halal market and MIHAS’ commitment to catering to its multifaceted demands.The 21st edition of MIHAS, under the theme “Pinnacle of Halal Excellence”, will place a special emphasis on fostering innovation and sustainable initiatives. These key focus areas are designed to spearhead steady growth for the Halal economy, ensuring that it remains vibrant and resilient in the face of global challenges. By encouraging local and international players to embrace innovative solutions and sustainable practices, MIHAS aims to not only enhance the competitiveness of the Halal industry but also to contribute to a more sustainable and inclusive global economy.MIHAS’s global reach is not confined to the ASEAN region alone; it enjoys robust international support, evidenced by the enthusiastic participation of International Pavilions from countries across the globe. This includes trade commissions, various government agencies, industry players, and market leaders, all coming together to explore and seize the vast opportunities within the Halal market. This international collaboration underscores MIHAS’s role as a global nexus for the Halal industry, facilitating cross-border trade, knowledge exchange, and fostering partnerships that span continents.As MIHAS continues to evolve, it remains committed to its mission of galvanising the global Halal industry, promoting innovation, and supporting sustainable growth. Through its comprehensive platform, MIHAS not only showcases the latest trends and innovations in the Halal sector but also catalyses forging business connections and dialogue that drive the industry forward. With each edition, MIHAS reaffirms its position as a key player in shaping the future of the global Halal economy.ABOUT THE MALAYSIA EXTERNAL TRADE DEVELOPMENT CORPORATION (MATRADE) The Malaysia External Trade Development Corporation (MATRADE) has been at the forefront of promoting Malaysia’s exports, playing a pivotal role in enabling many local companies to establish and expand their presence in global markets. As we continue to spotlight capable Malaysian companies on the international stage, our efforts are aimed at making the ‘Made-In-Malaysia’ brand synonymous with excellence, reliability, and trustworthiness. This commitment is reflected in our strategic initiatives and comprehensive support programmes designed to empower Malaysian exporters to navigate and succeed in the competitive global marketplace.Underpinning MATRADE’s mission is a deep-seated belief in the quality, innovation, and diversity of Malaysian products and services. By fostering a conducive environment for export growth, MATRADE has been instrumental in helping Malaysian businesses not only enter but also thrive in new and existing markets worldwide. Our approach is holistic, encompassing market intelligence, trade advisory services, and capacity-building programs, all tailored to the nuanced needs of Malaysian exporters.MATRADE’s efforts extend beyond traditional trade facilitation. We are committed to championing the Halal industry, as evidenced by our pivotal role in organising the Malaysia International Halal Showcase (MIHAS).Furthermore, MATRADE’s dedication to sustainability and digitalisation reflects our forward-thinking approach to trade promotion. By integrating these elements into our initiatives, we aim to ensure that Malaysian exporters are well-equipped to meet the evolving demands of the global market, thereby securing Malaysia's economic future and reinforcing our position as a trusted trading partner.As we look to the future, MATRADE remains steadfast in its mission to elevate Malaysia’s export landscape. Through strategic partnerships, innovative programs, and a relentless focus on quality and excellence, we are helping to shape a resilient and dynamic Malaysian export sector that is capable of achieving sustainable growth on the global stage.Issued by MNAIR PR Consultancy Sdn Bhd on behalf of Malaysia External Trade Development Corporation (MATRADE)Contacts for Media Enquiries:  MNAIR PR Consultancy Sdn BhdAmeera HaniAssociate Director, Public Relations+6014 224 3296ameera@mnairpr.comNoor Fadilah IbrahimConsultant, Public Relations+6017 291 0711noorfadilah@mnairpr.comMalaysia External Trade Development Corporation (MATRADE)Aninawati SalehHead, Corporate Communication+6013 890 9226aninawati@matrade.gov.my  Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

香港，2025年9月16日 - (亞太商訊 via SeaPRwire.com) - 國泰海通集團下屬公司國泰君安國際控股有限公司（「國泰君安國際」，股票代碼：1788.HK）作爲聯席保薦人、保薦人兼整體協調人、整體協調人、聯席全球協調人、聯席賬薄管理人及聯席牽頭經辦人，助力全球領先的激光雷達公司禾賽科技 （股票代碼：2525. HK）于9月16日在香港聯合交易所主板成功上市，本次禾賽科技港股上市是自2022年以來募資規模最大的中概股回歸項目，彰顯了國泰海通集團在跨境資本運作中高效整合境內外資源優勢的卓越能力。禾賽科技作爲全球領先的激光雷達製造商，此前已于美國上市，專注于激光雷達産品的設計、研發、製造與銷售。其産品廣泛應用于配備高級駕駛輔助系統的乘用車、商用車、自動駕駛車隊、機器人及其他非汽車領域，如自動導引車、自主移動機器人和配送機器人等。根據灼識諮詢報告，禾賽科技在2022年至2024年連續三年收入規模位居全球激光雷達行業首位，毛利率與毛利水平亦在全球同行業中排名第一。截至2024年12月，禾賽科技成爲全球首家實現單月出貨量突破10萬台的激光雷達企業，幷率先成爲行業內産生正營運現金流的上市公司。禾賽科技本次港股成功上市，是國泰海通集團充分調動境內外資源優勢的又一典型案例。在本項目的推進中，國泰君安國際充分發揮其溝通協調與執行能力，開展扎實深入的市場推介工作，不僅助力禾賽科技成爲2022年以來最大募資規模的中概股回歸香港市場幷實現美股與港股雙重主要上市的項目，也助力禾賽科技成爲2023年以來第一家以不同投票權架構回歸港股的美股中概股企業。本次發行最終定價爲每股212.8港元，幷悉數行使發售量調整權，額外發行255萬股，總發售股數達1955萬股，總集資額升至41.6億港元。國際配售錄得踴躍認購，認購倍數達14.09倍。公司計劃將募集資金的約50%用于研發投入，35%用于擴大生産能力，5%用于業務拓展，10%作爲營運資金及一般企業用途。本項目成功引入多名基石投資者，包括高瓴旗下HHLR Advisors、泰康人壽、WT Asset Management、Grab、宏達集團和康曼德，認購總額約1.48億美元，體現了國際資本市場對禾賽科技長期投資價值與成長潜力的高度認可。 Copyright 2025 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com